Delivery Order SPE2DB20D1100-SPE2DB24FB1Y1
Award Date
4/10/24
Potential Completion Date
4/11/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Omnipaque 350 mg/ml pluspak 500 ml pharmaceutical products. The delivery order has a potential value of $1,010.10 and a performance period through March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) valued up to $999,999,999.00 that serves as the primary vehicle for the...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of Omnipaque 300 mg/ml medical products. The $2,179.18 firm-fixed-price contract has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of Omnipaque 300 mg/ml infusion bottles (150 ml) to the Defense Logistics Agency (DLA). The $1,800.47 Firm Fixed Price contract is a Delivery Order awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide OMNIPAQUE 350 MG/ML PLUSPAK 500ML pharmaceutical products. The $6,937.87 contract has a performance period through March 29, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The contract has a ceiling value of $3,498.20 and an ultimate completion date of September 4, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,984.20 firm fixed-price delivery order is for the supply of Omnipaque 350 mg/ml infusion bottles, a radiopaque contrast agent used in medical imaging procedures. The contract has a completion date of July 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $5,856.20 to Amerisourcebergen Drug Corporation for the supply of 100 milliliters of Omnipaque 350 mg/ml infusion bottles. The contract has a period of performance from September 18, 2023 through September 19, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Omnipaque 350 mg/ml Plus Pak 500ml, a radiopaque contrast agent. The $1,399.28 firm-fixed-price delivery order has a completion date of September 17, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,141.62, is a delivery order for the medical product "OMNIPAQUE 300 MG/ML PLUSPAK 500ML". The contract has an ultimate completion date of March 11, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OMNIPAQUE 350 MG/ML INFU BTL 75ML. The $3,038.50 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., which also does business as AmerisourceBergen. This IDC with the DLA Troop Support Medical serves as the primary vehicle for...